Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Oxford Nanopore

Oxford Nanopore

Oxford Nanopore Technologies was founded in 2005 to develop an electronic, single molecule sensing system based on nanopore science. The company now has more than 250 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialization. Oxford Nanopore's instruments — MinIon, PromethIon, and GridIon are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule.

Oxford Nanopore Facts

 

CEO: Gordon Sanghera

Website: www.nanoporetech.com

Ticker symbol: Privately held

Headquarters: Oxford, UK

Number of employees: 250+

Jun 26, 2020

New Products Posted to GenomeWeb: Oxford Nanopore, Guardant Health, IDT, More

May 28, 2020

Oxford Nanopore Technologies Raises £48.4M in Private Financing

The company is also working on a diagnostic COVID-19 test, called LamPore, that will run on its MinIon and GridIon nanopore sequencing platforms

Apr 22, 2020

New Zealand Funds Research Pairing Ubiquitome, Oxford Nanopore Devices for SARS-CoV-2 Detection

Combining Ubiquitome's handheld PCR device and Oxford Nanopore's sequencer may enable a single person to screen 500 samples and obtain 24 whole genome sequences per day.

Apr 10, 2020

Korean Researchers Map SARS-CoV-2 Transcriptomic Architecture

The researchers said a functional investigation of the virus' unknown transcripts and RNA modifications will elucidate its life cycle and pathogenicity.

Mar 31, 2020

The Decade in Genomics: CRISPR, Single Cells, Long Reads, Clinical and Consumer Applications

Premium

GenomeWeb asked a number of prominent researchers in the field via email about their top picks for notable developments or achievements in genomics during the 2010s.

Mar 25, 2020

UK COVID-19 Sequencing Consortium to Reveal Viral Spread, Evolution

A nationwide, multi-agency effort to sequence the virus causing COVID-19 is a logistical nightmare, but experts say the UK is well situated to succeed.

Mar 18, 2020

Jury Invalidates Pacific Biosciences Patents in Lawsuit Against Oxford Nanopore

The Delaware jury said Oxford Nanopore had infringed three patents, but also found that they were invalid, mostly because they were not enabled.

Mar 11, 2020

Genome Research Papers on Viral Genomes, Brain RNA Interactions in Autism, More

In Genome Research this week: approach to isolate viral genomes from metagenomic sequence collections, regulatory shifts in individuals with autism spectrum disorder, and more.

Mar 05, 2020

New Sepsis Test Uses Nanopore Sequencing to Detect Pathogens From Cell-Free DNA

Premium

The method uses nanopore sequencing to analyze short cell-free DNA fragments from blood, providing results in as little as six hours.

Feb 27, 2020

Oxford Nanopore Licenses NuProbe Sample Prep Technology

NuProbe's blocker displacement amplification technology selectively amplifies low-abundance sequence variants in a background of wildtype DNA.

Pages

The Scan

Working Out the Effect

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Increased Genetic Privacy in Florida

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

Attention-Grabbing in Two Ways

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

Nature Papers Describe CRISPR Plant Editing Methods, DNA-PAINT Improvements, More

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.